Skip to main content
. 2023 Jan 10;7:22. Originally published 2022 Jan 24. [Version 3] doi: 10.12688/wellcomeopenres.17403.3

Figure 1. Prevalence of comorbidities among COPD patients with COVID-19 who have been diagnosed (red) and hospitalized (blue).

Figure 1.

*Databases contributing patients to both the diagnosed and hospitalized cohorts. T2DM=Type 2 diabetes mellitus. MI=myocardial infarction. CVD=Cerebrovascular disease. CLD=chronic liver disease. CKD=chronic kidney disease. Autoimmune Cond.=autoimmune conditions. CVS=Cardiovascular.